Skip Navigation
Print This Page  Print

November 01, 2021  |  News Category: Hospital News, COVID-19

Booster Flyer


Scotland Health is excited to announce booster shots are now available to the public. Shots are being offered in five of Scotland Health’s primary care clinics in addition to a daily drive-thru clinic on the campus of Scotland Memorial Hospital. 

The five clinics offering shots are: Harris Family Practice, Marlboro Family Practice, Maxton Family Practice, Pembroke Family Practice and Wagram Family Practice. Appointments are required and can be made by calling any of the practices listed above. 

To make an appointment at the drive thru clinic, call 910-291-7654. This clinic operates Monday – Thursday from 9:00 am – 4:00 pm and Friday from 9:00 am – 2:00 pm. 
Moderna & Pfizer booster shots can now be administered six months after the second dose to: 

  • People aged 65 years and older
  • Residents aged 18 years and older in long-term care settings
  • People aged 18-64 years with underlying medical conditions 
  • People aged 18-64 years at increased risk for COVID-19 exposure and transmission because of occupational or institutional setting 

“There are still many community members who remain unvaccinated, leaving themselves, their children, families, loved ones, and community members vulnerable. We continue to encourage everyone eligible to get an initial COVID-19 vaccine. We have made it as convenient as possible to receive first, second, third and booster doses. It is important for people to know flu vaccines and covid vaccines can be given together and do not require a waiting period in between. Vaccination remain the best way to protect yourself and reduce the spread of the virus and help prevent new variants from emerging,” stated Dr. Shelly Lowery, Chief Medical Officer for Scotland Physicians Network.

The latest CDC recommendations allow people to receive a different booster from what they originally received. Available data right now show that all three of the COVID-19 vaccines approved or authorized in the United States continue to be highly effective in reducing risk of severe disease, hospitalization, and death, even against the widely circulating Delta variant per the CDC.